Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia
Clinical trial NCT00485810 · COMPLETED
Trial details
- NCT number
- NCT00485810
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.